AVEO Pharmaceuticals (AVEO) Misses Q3 EPS by 6c

AVEO Pharmaceuticals (NASDAQ: AVEO) reported Q3 EPS of ($0.27), $0.06 worse than the analyst estimate of ($0.21). Revenue for the quarter came in at $115 thousand versus the consensus estimate of $3.25 million.

For earnings history and earnings-related data on AVEO Pharmaceuticals (AVEO) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery